Bausart, M.; Vanvarenberg, K.; Ucakar, B.; Lopes, A.; Vandermeulen, G.; Malfanti, A.; Préat, V.
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model. Pharmaceutics 2022, 14, 1025.
https://doi.org/10.3390/pharmaceutics14051025
AMA Style
Bausart M, Vanvarenberg K, Ucakar B, Lopes A, Vandermeulen G, Malfanti A, Préat V.
Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model. Pharmaceutics. 2022; 14(5):1025.
https://doi.org/10.3390/pharmaceutics14051025
Chicago/Turabian Style
Bausart, Mathilde, Kevin Vanvarenberg, Bernard Ucakar, Alessandra Lopes, Gaëlle Vandermeulen, Alessio Malfanti, and Véronique Préat.
2022. "Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model" Pharmaceutics 14, no. 5: 1025.
https://doi.org/10.3390/pharmaceutics14051025
APA Style
Bausart, M., Vanvarenberg, K., Ucakar, B., Lopes, A., Vandermeulen, G., Malfanti, A., & Préat, V.
(2022). Combination of DNA Vaccine and Immune Checkpoint Blockades Improves the Immune Response in an Orthotopic Unresectable Glioblastoma Model. Pharmaceutics, 14(5), 1025.
https://doi.org/10.3390/pharmaceutics14051025